Li Lab: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(141 intermediate revisions by the same user not shown)
Line 6: Line 6:
<div style="float:left;margin-left:0.3em;margin-right:0.7em">
<div style="float:left;margin-left:0.3em;margin-right:0.7em">


== '''Welcome to Wei Li's Computational Genomics Lab''' ==  
== '''Computational Epigenomics and Transcriptomics Lab (PI: Wei Li)''' ==  


[http://www.bcm.edu/cancercenter/ Dan L. Duncan Cancer Center], [http://www.bcm.edu/mcb/index.html Department of Molecular and Cellular Biology], [http://www.bcm.edu/ Baylor College of Medicine]
[http://www.bcm.edu/cancercenter/ Dan L. Duncan Cancer Center], [http://www.bcm.edu/mcb/index.html Department of Molecular and Cellular Biology], [http://www.bcm.edu/ Baylor College of Medicine]
Line 15: Line 15:


==Recent News==
==Recent News==
. 12/2010Liguo's fly RNA-seq paper has been published in '''Genome Research'''.
. 09/2013Zheng's prostate cancer RNA-seq paper with Dr. Balk at Harvard is accepted in '''Molecular Cancer Research '''.


. 10/2010A Texas '''CPRIT grant''' has been funded. We will work with Dr. Goodell at BCM to understand DNA Methylgransferase 3B in normal and malignant hematopoiesis.  
. 08/2013Zheng's DaPars 3'UTR Pan Cancer analysis paper is accepted in principle in '''Nature Communications'''.


. 08/2010Our '''Pilot Project''' has been funded by a NIH Stem Cell P01 Grant.  
. 08/2014Liguo's RSeQC paper is ranked No. 15 in the [http://bioinformatics.oxfordjournals.org/reports/most-cited Most-Cited Articles] in Bioinformatics as of August 1, 2014.


. 07/2010The DNA methylation platform comparision paper has been accepted to '''Nature Biotechnology'''.
. 08/2014:  '''Three Collaboration CPRIT grants''' are funded: DNA methylation with Goodell lab, 3'UTR with Wagner lab and ZM11 with Shi lab.


. 06/2010: Hao Zhao will join us as a '''postdoc fellow'''. Hao has a PhD in Computer Science from City University of Hong Kong.  Welcome!
. 08/2014: Kaifu's "super promoter" paper is under review in '''Nature Genetics'''.  


. 05/2010Our paper titled "Histone modifications and chromatin organization in prostate cancer" has been accepted by '''Epigenomics'''.
. 06/2014Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to '''Cell Stem Cell '''.  


. 01/2010A Texas '''CPRIT grant''' has been funded. We will use ChIP-seq and RNA-seq to analyze Androgen Receptor (AR) function in Prostate Cancer with Dr. Weigel at BCM.
. 06/2014Zheng's alternative splicing paper (with the Cooper Lab) is accepted to '''Molecular Cell '''.  


. 01/2010A '''CPRIT multi-investigator planning award''' has been funded. This project will bring together a "dream team" in epigenetics research.  We will direct the bioinformatics component for LONESTAR.
. 04/2014Liguo's ChIP-exo methodology paper (MACE) is accepted in principle in '''Nucleic Acids Research'''.  


. 01/2010Wei Li is an invited speaker in the American Association for Cancer Research (AACR) Special '''Conference on Cancer Epigenetics''' at Puerto Rico.
. 02/2014DQ and HJ's HSC LncRNA paper (with the Goodell Lab) is in revision in '''Cell Stem Cell'''.  


. 12/24/2009Dr.Bert O'Malley's SRC-3 ChIP-seq paper has been accepted by '''Molecular Endocrinology'''. Liguo and Wei are co-authors on the paper.
. 02/2014Zheng's collaborative work on alternative splicing in heart development is accepted to '''Nature Communications'''.  


. 12/08/2009Liguo's RNA-seq methodology paper has been accepted by '''PLoS ONE'''. Congratulations Liguo!
. 02/2014Zheng's brain tumor 3'UTR regulator paper is accepted to '''Nature'''. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.


. 11/13/2009Wei Li received a '''New Investigator Award''' from the Department of Defense (DOD) Prostate Cancer Research Program (PCRP). Cheers!
. 02/2014Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.


. 11/07/2009Wei Li gave a '''Keynote Presentation''' at the Symposium on Advances in Cell Signaling, Cancer Prevention and Therapy at South Padre Island, Texas.
. 02/2014Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to '''Cell Stem Cell'''.


. 09/29/2009A prestigious '''NIH Challenge grant''' has been funded. We will use ChIP-seq to analyze RXRa binding in mouse liver with Dr. Karpen at Texas Children's Hospital.
. 01/2014Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to '''Genome Biology'''.


. 09/17/2009A two-year $2.5 million '''NIH Grand Opportunity (GO) grant''' has been funded. We will study aging epigenomics with Drs. Darlington and Goodell at BCM.
. 01/2014Our collaborative work on Breast Cancer Epigenetics is accepted to '''Science Translational Medicine'''.


. 09/15/2009A prestigious '''NIH Challenge grant''' has been funded. We will use RNA-seq to characterize patient cardiac progenitors with Dr. Pu at Harvard Medical School.
. 01/2014Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to '''Nature'''. This work links transcription elongation to tumor suppression.


. 06/05/2009: Yuanxin's Bisulfite Sequence Mapping paper has been accepted by '''BMC Bioinformatics'''. Congratulations Yuanxin!
. 12/2013: Kaifu's aging nucleosome paper is accepted to ''' Genes & Development'''  


. 03/26/2009: Wei's paper titled 'Reprogrammed Androgen Receptor Function in Androgen-Independent Prostate Cancer' has been accepted by '''Cell'''.
. 12/2013: We received a 5-year NIH/NHGRI '''R01''' grant (scored at 6 percentile in its first submission) to study DNA Methylation


. 11/2013: Wei will serve on the Editorial Board of '''Molecular Endocrinology'''


. 09/2013:  Deqiang's DNA methylation Canyon paper is accepted to '''Nature Genetics'''.
. 09/2013:  Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to '''Bioinformatics'''.
. 08/2013:  Kadir's p53 paper is accepted to '''Nucleic Acids Research'''
. 01/2013:  [http://www.bcm.edu/news/item.cfm?newsID=6723 BCM News] and  [http://epigenie.com/danpos-reveals-dynamic-nucleosomes Epigenie Headline] about our recent work on nucleosome dynamics.
[[Image:Banner.jpg‎‎]]


[http://openwetware.org/wiki/Li_Lab:news News Archive]
[http://openwetware.org/wiki/Li_Lab:news News Archive]
Line 57: Line 68:
{|width="*"
{|width="*"
|
|
{| style="width: 100%;  text-align:center;font-size:12px;font-variant: small-caps;width: 18px; " align="center"  
{| style="width: 728px;  text-align:center;font-size:12px;font-variant: small-caps;width: 18px; " align="center"  
|-
|-


Line 73: Line 84:
<div style="border-bottom: 1px dashed #9999CC;">
<div style="border-bottom: 1px dashed #9999CC;">


== '''A Genomic View of Epigenetic and Transcriptional Regulation''' ==
Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers in high profile journals, such as Nature, Cell, Nature Genetics, Molecular Cell, Genome Research, Genome Biology, Genes and Development, Nucleic Acids Research, Cancer Research, PNAS and Bioinformatics.
 
We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.
 
In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.


* Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 pioneer factor, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.


Our lab is focused on the design and application of bioinformatics algorithms to elucidate global regulatory mechanism by integrating data from ChIP-seq, DNA methylation, Nucleosome positioning, and RNA-seq.  We are also working with bench and clinical collaborators to understand epigenetic gene regulation in various biological processes and disease models.  
* DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon, HSC aging.  


We have developed a number of widely used algorithms to detect and annotate genome-wide cis-regulatory regions, including a Hidden Markov Model (Bioinformatics 2005) and MAT (PNAS 2006) for analyzing ChIP-chip experiments on genome tiling arrays, CEAS (NAR 2006) for cis-regulatory element annotation, xMAN (BMC Genomics 2008) for microarray probe mapping, MACS (Genome Biology 2008) for model based analysis of ChIP-seq, BSMAP (BMC Bioinformatics 2009) for DNA methylation analysis using Bisulfite-seq, and MMES (PLoS ONE 2010) for alternative splicing using RNA-seq. These algorithms have gathered thousands of academic users worldwide and hundreds of citations, including > 30 papers in Cell and Nature serious. We are currently working on bioinformatics development for 1) Transcription factor binding and histone modifications (ChIP-seq); 2) DNA methylation at single nucleotide resolution (Bisulfite-seq); 3) Nucleosome remodeling (Mnase-seq); 4) Alternative splicing (RNA-seq).
* Nucleosome Organization: fragile nucleosome in gene poising, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.


We have extensive experience in collaborative research, such as Estrogen Receptor (ER) in breast cancer (Cell 2005; Nature Genetics 2006), Androgen Receptor (AR) in prostate cancer (Molecular Cell 2007; Cell 2009) and ER/AR’s collaborating factor FoxA1 (Cell 2008). My laboratory also plays an important role in the BCM Epigenomics Data Analysis and Coordination Center for a five-year NIH Roadmap Epigenomics Program.  
* Transcriptome: chimeric RNA in prostate cancer, Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.


[http://sites.google.com/a/bcm.edu/lilab/ Lab Intranet]
[http://sites.google.com/a/bcm.edu/lilab/ Lab Intranet]
[http://openwetware.org/wiki/Li_Lab openwetware]
[http://openwetware.org/wiki/Li_Lab openwetware]

Revision as of 10:56, 1 September 2014

Home        People        Publications        Collaborations        Software        Positions        Contact       


Recent News

. 09/2013: Zheng's prostate cancer RNA-seq paper with Dr. Balk at Harvard is accepted in Molecular Cancer Research .

. 08/2013: Zheng's DaPars 3'UTR Pan Cancer analysis paper is accepted in principle in Nature Communications.

. 08/2014: Liguo's RSeQC paper is ranked No. 15 in the Most-Cited Articles in Bioinformatics as of August 1, 2014.

. 08/2014: Three Collaboration CPRIT grants are funded: DNA methylation with Goodell lab, 3'UTR with Wagner lab and ZM11 with Shi lab.

. 08/2014: Kaifu's "super promoter" paper is under review in Nature Genetics.

. 06/2014: Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to Cell Stem Cell .

. 06/2014: Zheng's alternative splicing paper (with the Cooper Lab) is accepted to Molecular Cell .

. 04/2014: Liguo's ChIP-exo methodology paper (MACE) is accepted in principle in Nucleic Acids Research.

. 02/2014: DQ and HJ's HSC LncRNA paper (with the Goodell Lab) is in revision in Cell Stem Cell.

. 02/2014: Zheng's collaborative work on alternative splicing in heart development is accepted to Nature Communications.

. 02/2014: Zheng's brain tumor 3'UTR regulator paper is accepted to Nature. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.

. 02/2014: Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.

. 02/2014: Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to Cell Stem Cell.

. 01/2014: Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to Genome Biology.

. 01/2014: Our collaborative work on Breast Cancer Epigenetics is accepted to Science Translational Medicine.

. 01/2014: Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to Nature. This work links transcription elongation to tumor suppression.

. 12/2013: Kaifu's aging nucleosome paper is accepted to Genes & Development

. 12/2013: We received a 5-year NIH/NHGRI R01 grant (scored at 6 percentile in its first submission) to study DNA Methylation

. 11/2013: Wei will serve on the Editorial Board of Molecular Endocrinology

. 09/2013: Deqiang's DNA methylation Canyon paper is accepted to Nature Genetics.

. 09/2013: Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to Bioinformatics.

. 08/2013: Kadir's p53 paper is accepted to Nucleic Acids Research

. 01/2013: BCM News and Epigenie Headline about our recent work on nucleosome dynamics.


News Archive




Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms and transcription dynamics in normal development and diseases such as cancer. Since establishing the lab in early 2008, we have published more than 50 peer-reviewed papers in high profile journals, such as Nature, Cell, Nature Genetics, Molecular Cell, Genome Research, Genome Biology, Genes and Development, Nucleic Acids Research, Cancer Research, PNAS and Bioinformatics.

We developed a number of widely used algorithms to analyze next generation sequencing data from Chromatin Factor ChIP-seq (MACS, MACE, DyChIPS), DNA Methylation Bisulfite-seq (BSMAP/RRBSMAP, BSeQC, MOABS), Nucleosome Positioning MNase-seq (DANPOS), and RNA-seq (CPAT, RSeQC, DaPars). These algorithms have been broadly adopted by thousands of academic users. For example, the MACS algorithm has gathered >1000 citations since 2008.

In collaboration with experimental biologists, we used these algorithms to gain novel biological insights from various biological processes and disease models.

  • Chromatin Factors: ER in breast cancer, AR in prostate cancer, FoxA1 pioneer factor, Atoh1 in neuron development, NSD2 in oncogenic programming, SIRT7 in cancer transformation, ZM11 in transcription elongation, and p53 in ES differentiation.
  • DNA Methylation: Dnmt3a in HSC differentiation, DNA methylation Canyon, HSC aging.
  • Nucleosome Organization: fragile nucleosome in gene poising, promoter nucleosome with Tup1, nucleosome dynamics in ES differentiation, global nucleosome loss in aging.
  • Transcriptome: chimeric RNA in prostate cancer, Long non-coding RNA in HSC, 3’UTR deletion in cancer and their master regulators.


Lab Intranet openwetware


<html> <script type="text/javascript">

 var _gaq = _gaq || [];
 _gaq.push(['_setAccount', 'UA-5924762-2']);
 _gaq.push(['_trackPageview']);
 (function() {
   var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
   ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
   var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
 })();

</script> </html>